Benjamin Wainstain

Private Equity Investor chez

Innovacom Gestion SAS

Finance

Consumer Services

Producer Manufacturing

Profil

Benjamin Wainstain is currently a Partner at Innovacom Gestion SAS since 2020.
Prior to this, he worked as an Investment Director at Demeter Partners SA from 2012 to 2019.
He also held positions as a Director at SymbioFCell SA, BW Ideol, and I-TEN SA. Before that, he worked as an Investment Manager at CEA Investissement SA from 2008 to 2011.
Mr. Wainstain received his graduate degree from the University of Marseille and his undergraduate degree from Ecole Polytechnique.

Postes actifs de Benjamin Wainstain

Sociétés	Poste	Début
Innovacom Gestion SAS Innovacom Gestion SAS Investment ManagersFinance Innovacom Gestion SAS is an active investment manager focused on Europe and North America. The firm invests at early stage in emerging business, projects and start-ups operating in the telecommunication and information technology industries including components, hardware, software and telecommunications equipment. Innovacom usually acquires minority stakes in the portfolio company.	Private Equity Investor	01/09/2020

Tous les postes actifs de Benjamin Wainstain

Anciens postes connus de Benjamin Wainstain

Sociétés	Poste	Fin
Demeter Partners SA Demeter Partners SA Investment ManagersFinance Demeter Partners is an active manager which invests primarily in unlisted French and European small- to medium-sized companies in the eco-industries, eco-energies and modern-day hazards sectors. The firm invests mainly during the capital development phase, taking a minority stake and partnering with management to help create value in companies with strong growth potential. They also participate in LBO or pre-IPO projects in syndication with other funds, when companies are purchased or transferred. The Demeter Partners advisory board provides investment guidance to the management team.	Analyste en capital-investissement	01/07/2019
CEA Investissement SA CEA Investissement SA Investment ManagersFinance CEA-I focuses on high-technology sectors where CEA conducts research. In particular, CEA-I has scientific and technical expertise in micro- and nano-technologies, biotechnology and medical technology, systems and software, advanced materials and innovation in the field of energy. The firm specializes in seed capital and early-stage investment in businesses based either on CEA research or on third-party research in a domain where CEA has expertise. CEA-I invests exclusively in the first financing round or before, generally in syndication with other venture capital firms. The firm acquires minority stakes, investing on average 500 thousand Euros. They seek board representation and participate in strategic decisions without interfering in daily operations. Their targeted exit horizon is five to eight years. Exit strategies include IPO and resale to financial or industrial partners. CEA-I also invests indirectly in early-stage French companies, in particular through funds managed by Grenoble-based venture capital firm Emertec Gestion in which they hold a minority interest.	Private Equity Investor	31/12/2011
PC Associés SAS PC Associés SAS Investment ManagersFinance IPSA is an active manager focused on science-based companies within the European Union. They invest internationally in the ICT, life sciences, natural resources and energy sectors, particularly in France, the UK, Germany, the Netherlands and Denmark. They target high-growth businesses with innovative technology and an experienced management team with a proven track record of growth. They seek board representation, actively participate in strategic decisions, and aim to build their portfolio companies into market leaders. The firm prefers to be the lead or co-lead investor and invests between EUR 1-5 million per round, participating in successive financing rounds. They invest across development stages from startups to pre-IPO companies, and accompany their portfolio companies throughout their development. They favor companies with disruptive products or technology which have reached an advanced stage of development, are likely to generate significant revenues within two to three years, and have exit visibility through IPO or trade sale. In the life sciences sector, IPSA focuses on clinical-stage drug development, medical devices, drug delivery and development services. Their ICT investments are in domains including content, software, enabling technology and infrastructure. The firm also invests in the energy and natural resources sector, focusing on exploration and production, as well as on renewable energy and clean technology.	Private Equity Investor	01/01/2009
BW Ideol BW Ideol Engineering & ConstructionIndustrial Services Designs and installs foundation solutions for the offshore wind industry	Directeur/Membre du Conseil	-
I-TEN SA I-TEN SA Electrical ProductsProducer Manufacturing Manufactures and markets micro batteries	Directeur/Membre du Conseil	-

Voir l'expérience en détail de Benjamin Wainstain

Formation de Benjamin Wainstain

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Benjamin Wainstain

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	9
Innovacom Gestion SAS Innovacom Gestion SAS Investment ManagersFinance Innovacom Gestion SAS is an active investment manager focused on Europe and North America. The firm invests at early stage in emerging business, projects and start-ups operating in the telecommunication and information technology industries including components, hardware, software and telecommunications equipment. Innovacom usually acquires minority stakes in the portfolio company.	Finance
PC Associés SAS PC Associés SAS Investment ManagersFinance IPSA is an active manager focused on science-based companies within the European Union. They invest internationally in the ICT, life sciences, natural resources and energy sectors, particularly in France, the UK, Germany, the Netherlands and Denmark. They target high-growth businesses with innovative technology and an experienced management team with a proven track record of growth. They seek board representation, actively participate in strategic decisions, and aim to build their portfolio companies into market leaders. The firm prefers to be the lead or co-lead investor and invests between EUR 1-5 million per round, participating in successive financing rounds. They invest across development stages from startups to pre-IPO companies, and accompany their portfolio companies throughout their development. They favor companies with disruptive products or technology which have reached an advanced stage of development, are likely to generate significant revenues within two to three years, and have exit visibility through IPO or trade sale. In the life sciences sector, IPSA focuses on clinical-stage drug development, medical devices, drug delivery and development services. Their ICT investments are in domains including content, software, enabling technology and infrastructure. The firm also invests in the energy and natural resources sector, focusing on exploration and production, as well as on renewable energy and clean technology.	Finance
University of Marseille University of Marseille Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ecole Polytechnique Ecole Polytechnique Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Demeter Partners SA Demeter Partners SA Investment ManagersFinance Demeter Partners is an active manager which invests primarily in unlisted French and European small- to medium-sized companies in the eco-industries, eco-energies and modern-day hazards sectors. The firm invests mainly during the capital development phase, taking a minority stake and partnering with management to help create value in companies with strong growth potential. They also participate in LBO or pre-IPO projects in syndication with other funds, when companies are purchased or transferred. The Demeter Partners advisory board provides investment guidance to the management team.	Finance
CEA Investissement SA CEA Investissement SA Investment ManagersFinance CEA-I focuses on high-technology sectors where CEA conducts research. In particular, CEA-I has scientific and technical expertise in micro- and nano-technologies, biotechnology and medical technology, systems and software, advanced materials and innovation in the field of energy. The firm specializes in seed capital and early-stage investment in businesses based either on CEA research or on third-party research in a domain where CEA has expertise. CEA-I invests exclusively in the first financing round or before, generally in syndication with other venture capital firms. The firm acquires minority stakes, investing on average 500 thousand Euros. They seek board representation and participate in strategic decisions without interfering in daily operations. Their targeted exit horizon is five to eight years. Exit strategies include IPO and resale to financial or industrial partners. CEA-I also invests indirectly in early-stage French companies, in particular through funds managed by Grenoble-based venture capital firm Emertec Gestion in which they hold a minority interest.	Finance
SymbioFCell SA SymbioFCell SA Electrical ProductsProducer Manufacturing Manufactures hydrogen fuel systems	Producer Manufacturing
BW Ideol BW Ideol Engineering & ConstructionIndustrial Services Designs and installs foundation solutions for the offshore wind industry	Industrial Services
I-TEN SA I-TEN SA Electrical ProductsProducer Manufacturing Manufactures and markets micro batteries	Producer Manufacturing